CLINICAL_TRIALS
trial_result
· 2021-07-14
Clinical Trial Update: Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase [Phase 2]
Summary
Phase 2 trial of LBH589 in adults with refractory chronic myeloid leukemia in chronic phase (terminated; results posted).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myeloid Leukemia in Chronic Phase | Phase 2 | Status: TERMINATED | Results posted: 2021-07-14